Karlis Pauksens

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 254 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Anthony L. Cunningham, Thomas C. Heineman, Himal Lal et al. · The Journal of Infectious Diseases · 2018 · 200 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Lisa A. Jackson, Alejandra Gurtman, Kathryn Rice et al. · Vaccine · 2013 · 189 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Clinical Efficacy and Safety of the Orally Inhaled Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza: a Randomized, Double-blind, Placebo-controlled European Study

Mika J. Mäkelä, Karlis Pauksens, Timo Rostila et al. · Journal of Infection · 2000 · 180 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study

Roman Chlíbek, Jan Smetana, Karlis Pauksens et al. · Vaccine · 2014 · 136 citations

Veterinary Medicine, Immunology, Infectious Diseases +16